您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Neuropeptide Y(scrambled)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Neuropeptide Y(scrambled)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Neuropeptide Y(scrambled)图片
包装:1mg
规格:98%
市场价:3159元
分子量:4253.7

产品介绍
Control peptide for neuropeptide Y (NPY)
货号:ajcx11040
CAS:
分子式:C190H287N55O57
分子量:4253.7
溶解度:Soluble to 1 mg/ml in H2O
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Scrambled Neuropeptide Y (scNPY) was similarly synthesized and contains the same amino acids as NPY, but scNPY is in a random sequence, it was used as a control in the research in NPY [1]. The sequence of scNPY is SKPQRDANREPTRYAIYDYSNPDIELHYLRPAYALG-NH2 [2].

Neuropeptide Y (NPY) is a 36-amino acid neuropeptide that exerts its activity via G-protein-coupled receptors. NPY is widely distributed in the peripheral and central nervous system. It modulates a variety of physiological processes, e.g. the central regulation of vasoconstriction, memory retention and food intake, and the regulation of circadian rhythm [2].

Scrambled NPY peptide treatment had no effect on VEGF expression in 4T1 cells. Previous treatment with scrambled NPY at concentrations ranging from 10?10 to 10?7 M made conditioned media from 4T1 cells show no difference in the number of complete endothelial networks or branch points versus control in endothelial tube formation assays [3].

In trimethyltin-treated (TMT-treated) rats, treatment with scrambled NPY for 24 h made the expression of Bdnf, NpyR, neurogenic and antiapoptotic genes comparable to that of saline-injected animals (without significant differences) [4]. In TMT-treated rats, both saline and scNPY showed no significant modulation (p>0.05) in the expression levels of Npy1R, Npy2R and Npy5R [5].

参考文献:
[1].  Boucha?b El Bahh, Silvia Balosso, Trevor Hamilton, et al. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y2 and not Y5 receptors. European Journal of Neuroscience, 2005, 22: 1417-1430.
[2].  Daniela Proske, Martin H?fliger, Richard M. S?ll, et al. A Y2 Receptor Mimetic Aptamer Directed against Neuropeptide Y. The Journal of Biological Chemistry, 2002, 277(13):11416-11422.
[3].  Philip J. Medeirosa and Dwayne N. Jackson. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis. Peptides, 2013, 48:106-113.
[4].  Valentina Corvino, Elisa Marchese, Stefano Giannetti, et al. The neuroprotective and neurogenic effects of neuropeptide Y administration in an animal model of hippocampal neurodegeneration and temporal lobe epilepsy induced by trimethyltin. J. Neurochem., 2012, 122: 415-426.
[5].  Valentina Corvino, Elisa Marchese, Maria Vittoria Podda, et al. The Neurogenic Effects of Exogenous Neuropeptide Y: Early Molecular Events and Long-lasting Effects in the Hippocampus of Trimethyltin-Treated Rats. PLOS ONE, 2014, 9(2): e88294.